We've found
8,177
archived clinical trials in
Orthopedic
We've found
8,177
archived clinical trials in
Orthopedic
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Updated: 3/9/2017
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Updated: 3/9/2017
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Click here to add this to my saved trials
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Updated: 3/9/2017
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Updated: 3/9/2017
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Click here to add this to my saved trials
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Updated: 3/9/2017
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Updated: 3/9/2017
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Click here to add this to my saved trials
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Updated: 3/9/2017
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Updated: 3/9/2017
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Click here to add this to my saved trials
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Updated: 3/9/2017
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Updated: 3/9/2017
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Click here to add this to my saved trials
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Updated: 3/9/2017
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Updated: 3/9/2017
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Click here to add this to my saved trials
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Updated: 3/9/2017
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Updated: 3/9/2017
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Click here to add this to my saved trials
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Updated: 3/9/2017
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Updated: 3/9/2017
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Click here to add this to my saved trials
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Updated: 3/9/2017
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Updated: 3/9/2017
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Click here to add this to my saved trials
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Updated: 3/9/2017
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Updated: 3/9/2017
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Click here to add this to my saved trials
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Updated: 3/9/2017
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Updated: 3/9/2017
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Click here to add this to my saved trials
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Updated: 3/9/2017
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Updated: 3/9/2017
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Click here to add this to my saved trials
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Updated: 3/9/2017
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Updated: 3/9/2017
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Click here to add this to my saved trials
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Updated: 3/9/2017
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Updated: 3/9/2017
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Click here to add this to my saved trials
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Updated: 3/9/2017
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Updated: 3/9/2017
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Click here to add this to my saved trials
Cardiovascular, Cerebrovascular, and Cognitive Function in Spinal Cord Injury
Updated: 3/9/2017
Cardiovascular, Cerebrovascular, and Cognitive Function in SCI
Status: Enrolling
Updated: 3/9/2017
Cardiovascular, Cerebrovascular, and Cognitive Function in Spinal Cord Injury
Updated: 3/9/2017
Cardiovascular, Cerebrovascular, and Cognitive Function in SCI
Status: Enrolling
Updated: 3/9/2017
Click here to add this to my saved trials
Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes
Updated: 3/14/2017
Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes
Status: Enrolling
Updated: 3/14/2017
Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes
Updated: 3/14/2017
Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes
Status: Enrolling
Updated: 3/14/2017
Click here to add this to my saved trials
Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes
Updated: 3/14/2017
Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes
Status: Enrolling
Updated: 3/14/2017
Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes
Updated: 3/14/2017
Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes
Status: Enrolling
Updated: 3/14/2017
Click here to add this to my saved trials
Bimodal Analgesia as Form of Pain Control Post Long Bone Fracture
Updated: 3/21/2017
Bimodal Analgesia as Form of Pain Control Post Long Bone Fracture
Status: Enrolling
Updated: 3/21/2017
Bimodal Analgesia as Form of Pain Control Post Long Bone Fracture
Updated: 3/21/2017
Bimodal Analgesia as Form of Pain Control Post Long Bone Fracture
Status: Enrolling
Updated: 3/21/2017
Click here to add this to my saved trials
Comparison of Two Types of Ankle Braces in the Management of Ankle Pain in Hemophilia
Updated: 4/3/2017
Comparison of Two Types of Ankle Braces in the Management of Ankle Pain in Hemophilia
Status: Enrolling
Updated: 4/3/2017
Comparison of Two Types of Ankle Braces in the Management of Ankle Pain in Hemophilia
Updated: 4/3/2017
Comparison of Two Types of Ankle Braces in the Management of Ankle Pain in Hemophilia
Status: Enrolling
Updated: 4/3/2017
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
Updated: 4/4/2017
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Bone Graft Materials Observational Registry
Updated: 4/4/2017
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
Updated: 4/4/2017
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Bone Graft Materials Observational Registry
Updated: 4/4/2017
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
Updated: 4/4/2017
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Bone Graft Materials Observational Registry
Updated: 4/4/2017
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
Updated: 4/4/2017
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Bone Graft Materials Observational Registry
Updated: 4/4/2017
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
Updated: 4/4/2017
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Bone Graft Materials Observational Registry
Updated: 4/4/2017
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
Updated: 4/4/2017
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Bone Graft Materials Observational Registry
Updated: 4/4/2017
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
Updated: 4/4/2017
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Bone Graft Materials Observational Registry
Updated: 4/4/2017
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
Updated: 4/4/2017
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Bone Graft Materials Observational Registry
Updated: 4/4/2017
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
Updated: 4/4/2017
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Bone Graft Materials Observational Registry
Updated: 4/4/2017
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
Updated: 4/4/2017
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Bone Graft Materials Observational Registry
Updated: 4/4/2017
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
Updated: 4/4/2017
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Bone Graft Materials Observational Registry
Updated: 4/4/2017
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
Updated: 4/4/2017
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Bone Graft Materials Observational Registry
Updated: 4/4/2017
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
Updated: 4/4/2017
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Bone Graft Materials Observational Registry
Updated: 4/4/2017
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
The Prevention of Myocardial Enlargement and Dilatation Post Myocardial Infarction Study
Updated: 4/4/2017
The Prevention of Myocardial Enlargement and Dilatation Post Myocardial Infarction Study
Status: Enrolling
Updated: 4/4/2017
The Prevention of Myocardial Enlargement and Dilatation Post Myocardial Infarction Study
Updated: 4/4/2017
The Prevention of Myocardial Enlargement and Dilatation Post Myocardial Infarction Study
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Rotator Cuff Repair (RCR) With and Without OrthoADAPT Augmentation
Updated: 4/4/2017
Rotator Cuff Repair (RCR) With and Without OrthoADAPT Augmentation
Status: Enrolling
Updated: 4/4/2017
Rotator Cuff Repair (RCR) With and Without OrthoADAPT Augmentation
Updated: 4/4/2017
Rotator Cuff Repair (RCR) With and Without OrthoADAPT Augmentation
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
An Open-label Safety, Tolerability, and Dose-range Finding Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA)
Updated: 4/5/2017
An Open-label, Escalating Dose Study to Assess the Safety, Tolerability and Dose-range Finding of a Single Intrathecal Dose of ISIS 396443 in Patients With Spinal Muscular Atrophy
Status: Enrolling
Updated: 4/5/2017
An Open-label Safety, Tolerability, and Dose-range Finding Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA)
Updated: 4/5/2017
An Open-label, Escalating Dose Study to Assess the Safety, Tolerability and Dose-range Finding of a Single Intrathecal Dose of ISIS 396443 in Patients With Spinal Muscular Atrophy
Status: Enrolling
Updated: 4/5/2017
Click here to add this to my saved trials
An Open-label Safety, Tolerability, and Dose-range Finding Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA)
Updated: 4/5/2017
An Open-label, Escalating Dose Study to Assess the Safety, Tolerability and Dose-range Finding of a Single Intrathecal Dose of ISIS 396443 in Patients With Spinal Muscular Atrophy
Status: Enrolling
Updated: 4/5/2017
An Open-label Safety, Tolerability, and Dose-range Finding Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA)
Updated: 4/5/2017
An Open-label, Escalating Dose Study to Assess the Safety, Tolerability and Dose-range Finding of a Single Intrathecal Dose of ISIS 396443 in Patients With Spinal Muscular Atrophy
Status: Enrolling
Updated: 4/5/2017
Click here to add this to my saved trials
An Open-label Safety, Tolerability, and Dose-range Finding Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA)
Updated: 4/5/2017
An Open-label, Escalating Dose Study to Assess the Safety, Tolerability and Dose-range Finding of a Single Intrathecal Dose of ISIS 396443 in Patients With Spinal Muscular Atrophy
Status: Enrolling
Updated: 4/5/2017
An Open-label Safety, Tolerability, and Dose-range Finding Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA)
Updated: 4/5/2017
An Open-label, Escalating Dose Study to Assess the Safety, Tolerability and Dose-range Finding of a Single Intrathecal Dose of ISIS 396443 in Patients With Spinal Muscular Atrophy
Status: Enrolling
Updated: 4/5/2017
Click here to add this to my saved trials
An Open-label Safety, Tolerability, and Dose-range Finding Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA)
Updated: 4/5/2017
An Open-label, Escalating Dose Study to Assess the Safety, Tolerability and Dose-range Finding of a Single Intrathecal Dose of ISIS 396443 in Patients With Spinal Muscular Atrophy
Status: Enrolling
Updated: 4/5/2017
An Open-label Safety, Tolerability, and Dose-range Finding Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA)
Updated: 4/5/2017
An Open-label, Escalating Dose Study to Assess the Safety, Tolerability and Dose-range Finding of a Single Intrathecal Dose of ISIS 396443 in Patients With Spinal Muscular Atrophy
Status: Enrolling
Updated: 4/5/2017
Click here to add this to my saved trials
Mechanism and Treatment of Sympathetically Maintained Pain
Status: Enrolling
Updated: 4/6/2017
Updated: 4/6/2017
Mechanism and Treatment of Sympathetically Maintained Pain
Status: Enrolling
Updated: 4/6/2017
Updated: 4/6/2017
Click here to add this to my saved trials
Healing With Venlafaxine After Injury (HELP)
Updated: 4/12/2017
Healing With Venlafaxine After Injury: A Randomized Clinical Trial of Venlafaxine Following Motor Vehicle Collision
Status: Enrolling
Updated: 4/12/2017
Healing With Venlafaxine After Injury (HELP)
Updated: 4/12/2017
Healing With Venlafaxine After Injury: A Randomized Clinical Trial of Venlafaxine Following Motor Vehicle Collision
Status: Enrolling
Updated: 4/12/2017
Click here to add this to my saved trials
Healing With Venlafaxine After Injury (HELP)
Updated: 4/12/2017
Healing With Venlafaxine After Injury: A Randomized Clinical Trial of Venlafaxine Following Motor Vehicle Collision
Status: Enrolling
Updated: 4/12/2017
Healing With Venlafaxine After Injury (HELP)
Updated: 4/12/2017
Healing With Venlafaxine After Injury: A Randomized Clinical Trial of Venlafaxine Following Motor Vehicle Collision
Status: Enrolling
Updated: 4/12/2017
Click here to add this to my saved trials
Healing With Venlafaxine After Injury (HELP)
Updated: 4/12/2017
Healing With Venlafaxine After Injury: A Randomized Clinical Trial of Venlafaxine Following Motor Vehicle Collision
Status: Enrolling
Updated: 4/12/2017
Healing With Venlafaxine After Injury (HELP)
Updated: 4/12/2017
Healing With Venlafaxine After Injury: A Randomized Clinical Trial of Venlafaxine Following Motor Vehicle Collision
Status: Enrolling
Updated: 4/12/2017
Click here to add this to my saved trials
Electrical Stimulation of the Sphenopalatine Ganglion for the Treatment of Migraine Headaches
Updated: 4/13/2017
Electrical Stimulation of the Sphenopalatine Ganglion for the Treatment of Migraine Headaches
Status: Enrolling
Updated: 4/13/2017
Electrical Stimulation of the Sphenopalatine Ganglion for the Treatment of Migraine Headaches
Updated: 4/13/2017
Electrical Stimulation of the Sphenopalatine Ganglion for the Treatment of Migraine Headaches
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials
A Prospective Study of Instrumented, Posterolateral Lumbar Fusions (PLF) With OsteoAMP®
Updated: 4/13/2017
A Prospective Study of Instrumented, Posterolateral Lumbar Fusions (PLF) With OsteoAMP® to Evaluate Long-Term Safety and Efficacy in Patients Requiring 1-2 Level Instrumented PLF
Status: Enrolling
Updated: 4/13/2017
A Prospective Study of Instrumented, Posterolateral Lumbar Fusions (PLF) With OsteoAMP®
Updated: 4/13/2017
A Prospective Study of Instrumented, Posterolateral Lumbar Fusions (PLF) With OsteoAMP® to Evaluate Long-Term Safety and Efficacy in Patients Requiring 1-2 Level Instrumented PLF
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials
A Prospective Study of Instrumented, Posterolateral Lumbar Fusions (PLF) With OsteoAMP®
Updated: 4/13/2017
A Prospective Study of Instrumented, Posterolateral Lumbar Fusions (PLF) With OsteoAMP® to Evaluate Long-Term Safety and Efficacy in Patients Requiring 1-2 Level Instrumented PLF
Status: Enrolling
Updated: 4/13/2017
A Prospective Study of Instrumented, Posterolateral Lumbar Fusions (PLF) With OsteoAMP®
Updated: 4/13/2017
A Prospective Study of Instrumented, Posterolateral Lumbar Fusions (PLF) With OsteoAMP® to Evaluate Long-Term Safety and Efficacy in Patients Requiring 1-2 Level Instrumented PLF
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials
A Prospective Study of Instrumented, Posterolateral Lumbar Fusions (PLF) With OsteoAMP®
Updated: 4/13/2017
A Prospective Study of Instrumented, Posterolateral Lumbar Fusions (PLF) With OsteoAMP® to Evaluate Long-Term Safety and Efficacy in Patients Requiring 1-2 Level Instrumented PLF
Status: Enrolling
Updated: 4/13/2017
A Prospective Study of Instrumented, Posterolateral Lumbar Fusions (PLF) With OsteoAMP®
Updated: 4/13/2017
A Prospective Study of Instrumented, Posterolateral Lumbar Fusions (PLF) With OsteoAMP® to Evaluate Long-Term Safety and Efficacy in Patients Requiring 1-2 Level Instrumented PLF
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials
A Prospective Study of Instrumented, Posterolateral Lumbar Fusions (PLF) With OsteoAMP®
Updated: 4/13/2017
A Prospective Study of Instrumented, Posterolateral Lumbar Fusions (PLF) With OsteoAMP® to Evaluate Long-Term Safety and Efficacy in Patients Requiring 1-2 Level Instrumented PLF
Status: Enrolling
Updated: 4/13/2017
A Prospective Study of Instrumented, Posterolateral Lumbar Fusions (PLF) With OsteoAMP®
Updated: 4/13/2017
A Prospective Study of Instrumented, Posterolateral Lumbar Fusions (PLF) With OsteoAMP® to Evaluate Long-Term Safety and Efficacy in Patients Requiring 1-2 Level Instrumented PLF
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials
A Prospective Study of Instrumented, Posterolateral Lumbar Fusions (PLF) With OsteoAMP®
Updated: 4/13/2017
A Prospective Study of Instrumented, Posterolateral Lumbar Fusions (PLF) With OsteoAMP® to Evaluate Long-Term Safety and Efficacy in Patients Requiring 1-2 Level Instrumented PLF
Status: Enrolling
Updated: 4/13/2017
A Prospective Study of Instrumented, Posterolateral Lumbar Fusions (PLF) With OsteoAMP®
Updated: 4/13/2017
A Prospective Study of Instrumented, Posterolateral Lumbar Fusions (PLF) With OsteoAMP® to Evaluate Long-Term Safety and Efficacy in Patients Requiring 1-2 Level Instrumented PLF
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials
A Prospective Study of Instrumented, Posterolateral Lumbar Fusions (PLF) With OsteoAMP®
Updated: 4/13/2017
A Prospective Study of Instrumented, Posterolateral Lumbar Fusions (PLF) With OsteoAMP® to Evaluate Long-Term Safety and Efficacy in Patients Requiring 1-2 Level Instrumented PLF
Status: Enrolling
Updated: 4/13/2017
A Prospective Study of Instrumented, Posterolateral Lumbar Fusions (PLF) With OsteoAMP®
Updated: 4/13/2017
A Prospective Study of Instrumented, Posterolateral Lumbar Fusions (PLF) With OsteoAMP® to Evaluate Long-Term Safety and Efficacy in Patients Requiring 1-2 Level Instrumented PLF
Status: Enrolling
Updated: 4/13/2017
Click here to add this to my saved trials